The Canadian animal pharmaceutical industry represents approximately 2.5% of the global industry, within the world’s second largest land mass (larger than the US), while having a small human population which is 10.5% that of the United States. In her paper, Jean Szkotnicki, President of CAHI, explores factors impacting the Canadian animal health business and the implications these will have on it and its customers.